Detalhe da pesquisa
1.
Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma.
Cancer Immunol Immunother
; 71(5): 1167-1181, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34623465
2.
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
Proc Natl Acad Sci U S A
; 116(5): 1692-1697, 2019 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635425
3.
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities.
Proc Natl Acad Sci U S A
; 113(42): 11919-11924, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27698113
4.
A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma.
BMC Cancer
; 18(1): 1274, 2018 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30567529
5.
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 18(4): 446-453, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223062
6.
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.
Lancet Oncol
; 15(1): 69-77, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24332512
7.
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
J Immunol
; 189(11): 5476-84, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23105141
8.
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
J Immunol
; 184(1): 452-65, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19949105
9.
Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy.
Psychosom Med
; 73(3): 218-25, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21257977
10.
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Nat Med
; 27(8): 1432-1441, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34239137
11.
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma.
Proc Natl Acad Sci U S A
; 104(52): 20884-9, 2007 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18093940
12.
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer.
Sci Transl Med
; 12(537)2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238575
13.
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Nat Med
; 26(1): 39-46, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31873309
14.
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
Neuro Oncol
; 22(4): 539-549, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755915
15.
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers.
Clin Cancer Res
; 25(4): 1233-1238, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30054281
16.
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma.
Cancer Immunol Res
; 7(9): 1390-1395, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289040
17.
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.
Cancer Immunol Res
; 7(11): 1803-1812, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31466995
18.
Characterization and Comparison of GITR Expression in Solid Tumors.
Clin Cancer Res
; 25(21): 6501-6510, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31358539
19.
A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology.
J Immune Based Ther Vaccines
; 6: 1, 2008 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-18321390
20.
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies.
Clin Cancer Res
; 24(5): 1011-1018, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29246938